CervoMed (CRVO) Other Operating Expenses (2010 - 2026)
CervoMed (CRVO) posted Other Operating Expenses of -$118624.0 for Q1 2026, up 49.99% sequentially from -$237209.0 in Q4 2025, and down 39.78% YoY from -$196999.4 in Q1 2025.
CervoMed (CRVO) Other Operating Expenses (2010 - 2026) Analysis & Trends
CervoMed has reported Other Operating Expenses for 9 years, with the latest figure at -$118624.0 in Q1 2026.
- Quarterly Other Operating Expenses fell 39.78% year-over-year to -$118624.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$466805.0 (down 72.88% YoY) and the FY2025 annual result came in at -$610561.0, down 93.9% from the prior year.
- Other Operating Expenses advanced to -$118624.0 in Q1 2026 per CRVO's latest filing, from -$237209.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at -$71878.0 in Q3 2024 and troughed at -$237209.0 in Q4 2025.
- A 3-year average of -$122803.8 and a median of -$112125.0 in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2025 and 2026: Other Operating Expenses tumbled 109.4% in 2025, then sank 39.78% in 2026.
- Over 3 years, Other Operating Expenses stood at -$113278.0 in 2024, then sank by 109.4% to -$237209.0 in 2025, then soared by 49.99% to -$118624.0 in 2026.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$118624.0, -$237209.0, and -$110972.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -121,670.00 |
| Mar 31, 2026 | -118,624.00 |
| Dec 31, 2025 | -237,209.00 |
| Sep 30, 2025 | -110,972.00 |
| Mar 31, 2025 | -84,862.00 |
| Dec 31, 2024 | -113,278.00 |
| Sep 30, 2024 | -71,878.00 |
| Dec 31, 2015 | 542,290.00 |
| Sep 30, 2015 | 11.88 Mn |
| Jun 30, 2015 | 1.71 Mn |
| Mar 31, 2015 | 2.33 Mn |
| Dec 31, 2014 | 6.11 Mn |
| Sep 30, 2014 | 368,924.00 |
| Jun 30, 2014 | 323,741.00 |
| Mar 31, 2014 | 191,330.00 |
| Dec 31, 2013 | -4.80 Mn |
| Sep 30, 2013 | 1.22 Mn |
| Jun 30, 2013 | 7.58 Mn |
| Mar 31, 2013 | 1.47 Mn |
| Dec 31, 2012 | 2.82 Mn |